ReviewCardiovascular diabetology2018

The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin.

Annayya R Aroor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.